Overview

Retrophin, Inc. is a biopharmaceutical company dedicated to developing therapies for rare diseases and unmet medical needs. The company focuses on discovering, developing, and marketing innovative treatments that have significant impacts on patients' lives.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Retrophin, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.